A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consor... by Hirva Mamdani, Bryan Schneider, Susan M. Perkins, Heather N. Burney, Pashtoon Murtaza Kasi, Laith I. Abushahin, Thomas Birdas, Kenneth Kesler, Tracy M. Watkins, Sunil S. Badve, Milan Radovich, Shadia I. Jalal

Get full text